Colgate Announces 2nd Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
UBS Raises Price Target on Colgate-Palmolive (CL) Following 2Q Report
July 29, 2016 9:03 AM EDTUBS reiterated a Neutral rating on Colgate-Palmolive Company (NYSE: CL), and raised the price target to $78.00 (from $76.00), following the company's 2Q earnings report. CL reported adjusted EPS of $0.70, ahead of consensus estimates of $0.69.
Analyst Stephen Powers commented, "CL delivered adj. Q2 EPS of... More
Exane BNP Paribas Downgrades Colgate-Palmolive Company (CL) to Neutral
July 29, 2016 6:39 AM EDTExane BNP Paribas downgraded Colgate-Palmolive Company (NYSE: CL) from Outperform to Neutral with a price target of $76 (unchanged).
For an analyst ratings summary and ratings history on Colgate-Palmolive Company click here. For more ratings news on Colgate-Palmolive Company click here.
Shares of Colgate-Palmolive Company closed at $73.25 yesterday.
... MoreColgate-Palmolive (CL) Misses Q2 EPS by 2c
July 28, 2016 6:58 AM EDTColgate-Palmolive (NYSE: CL) reported Q2 EPS of $0.67, $0.02 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $3.85 billion versus the consensus estimate of $3.86 billion.
For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.
... More